Circulation, Vol 75, 482-490, Copyright © 1987 by American Heart Association
G Heusch, BD Guth, R Seitelberger and J Ross Jr
There is now evidence that under resting conditions coronary vasodilator
reserve exists even in the presence of myocardial ischemia. Therefore, we
tested the hypothesis that a vasodilator reserve may exist during exercise
so that during exercise-induced ischemia a reduction in coronary
constrictor tone can be produced that attenuates the decreases in regional
myocardial blood flow and function distal to a severe coronary stenosis
without changing the determinants of myocardial oxygen demand. Nine dogs
were instrumented with an ameroid constrictor on the left circumflex
coronary artery and were studied 2 to 3 weeks later. During a control
treadmill run, heart rate increased from 119 +/- 20 to 225 +/- 20 beats/min
and peak left ventricular pressure increased from 144 +/- 17 to 163 +/- 28
mm Hg. Poststenotic subendocardial blood flow (measured by a microsphere
technique) fell from 1.19 +/- 0.36 to 0.51 +/- 0.30 ml/min X g and systolic
wall thickening (by sonomicrometry) decreased from 24.3 +/- 5.8% to 6.0 +/-
6.1%. During an identical run after nifedipine (10 micrograms/kg iv),
systemic hemodynamics were not significantly altered. However,
subendocardial blood flow was increased to 0.85 +/- 0.51 ml/min X g (p less
than .05) and systolic wall thickening to 11.4 +/- 7.8% (p less than .01).
We conclude that in this study the amelioration of exercise- induced
myocardial ischemia was due to the recruitment by nifedipine of coronary
vasodilator reserve.
ARTICLES
Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine
This article has been cited by other articles:
![]() |
D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch and R. Schulz The role of heart rate and the benefits of heart rate reduction in acute myocardial ischaemia Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F8 - F14. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Podesser, S. Schwarzacher, W. Zwoelfer, T. M. Binder, E. Wolner, and R. Seitelberger COMPARISON OF PERIOPERATIVE MYOCARDIAL PROTECTION WITH NIFEDIPINE VERSUS NIFEDIPINE AND METOPROLOL IN PATIENTS UNDERGOING ELECTIVE CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1461 - 1469. [Abstract] [Full Text] |
||||
![]() |
J. M. Canty Jr and T. P. Smith Jr Adenosine-Recruitable Flow Reserve Is Absent During Myocardial Ischemia in Unanesthetized Dogs Studied in the Basal State Circ. Res., June 1, 1995; 76(6): 1079 - 1087. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |